{
  "id": "72666c4b04e29b4a",
  "title": "AstraZeneca : ENHERTU Combination Approved In US For 1st - Line HER2 - Positive Metastatic Breast Cancer",
  "description": "20251216T050000Z",
  "content": "",
  "source": "finanzen.ch",
  "source_url": "https://www.finanzen.ch/nachrichten/aktien/astrazeneca-enhertu-combination-approved-in-us-for-1st-line-her2-positive-metastatic-breast-cancer-1035647494",
  "published_at": "20251216T050000Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Switzerland",
  "raw_data": {
    "url": "https://www.finanzen.ch/nachrichten/aktien/astrazeneca-enhertu-combination-approved-in-us-for-1st-line-her2-positive-metastatic-breast-cancer-1035647494",
    "url_mobile": "",
    "title": "AstraZeneca : ENHERTU Combination Approved In US For 1st - Line HER2 - Positive Metastatic Breast Cancer",
    "seendate": "20251216T050000Z",
    "socialimage": "",
    "domain": "finanzen.ch",
    "language": "English",
    "sourcecountry": "Switzerland"
  }
}